Connect with us

Healthcare

FDA gives official approval to Pfizer vaccine

Published

on

FinalFDAshutterstock 1044596995

[brid autoplay=”true” video=”698512″ player=”23886″ title=”moderna%20looking%20good%206%20million%20doses” duration=”24″ description=”undefined” uploaddate=”2021-01-04″ thumbnailurl=”//cdn.brid.tv/live/partners/18168/thumb/698512_t_1609803251.png” contentUrl=”//cdn.brid.tv/live/partners/18168/sd/698512.mp4″]


By Jenny Goldsberry

The U.S. became the first country to officially approve the Pfizer COVID-19 vaccine for everyone 16 years old and older Monday. It is currently the only vaccine fully licensed by the Food and Drug Administration.

According to a statement from the FDA, the vaccine received a new name and “will now be marketed as Comirnaty (koe-mir’-na-tee).”

“The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals,” the statement read.

Then, Acting FDA Commissioner Janet Woodcock, M.D. lauded the announcement. “The approval of this vaccine is a milestone as we continue to battle the COVID-19 pandemic,” Woodcock said in a statement. “While this and other vaccines have met the FDA’s rigorous, scientific standards for emergency use authorization, as the first FDA-approved COVID-19 vaccine, the public can be very confident that this vaccine meets the high standards for safety, effectiveness, and manufacturing quality the FDA requires of an approved product.”

Next Pfizer CEO Albert Bourla made a statement to commemorate the approval. Bourla hopes this latest update “will help increase confidence in our vaccine, as vaccination remains the best tool we have to help protect lives.”

You can follow Jenny Goldsberry on Twitter @jennyjournalism.

You may like

Continue Reading

education

FL bans puberty blockers, transgender surgery for minors

Published

on

Screen Shot 2020 07 24 at 4.10.33 PM

Breaking Friday, Florida’s Board of Medicine and state Board of Osteopathic Medicine voted to ban puberty blockers and sex-reassignment surgery for minors in the state.

“The chief point of agreement among all of the experts — and I must emphasize this — is that there is a pressing need for additional, high-quality clinical research,” said the board of medicine’s chair, Dr. David A. Diamond, a radiation oncologist.

More than 70 percent of children with gender dysphoria “typically outgrow” it, City Journal reported earlier this year.

National Review reports:

The board of medicine voted 6-3, with five others not present, on Friday to forbid doctors from prescribing puberty blockers and hormones or performing surgeries until a patient is 18. Exceptions will be made for children who are already receiving the treatment.

The Florida Board of Osteopathic Medicine also voted to ban the use of puberty blockers and sex-reassignment surgery in new patients who are minors but allowed an exception for children enrolled in clinical studies.

Florida is also one of at least nine states that prohibits Medicaid coverage of gender-transition services.

You may like

Continue Reading
Advertisement

Trending Now

Advertisement

Trending

Proudly Made In America | © 2022 M3 Media Management, LLC